Sanara MedTech (NASDAQ:SMTI) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.48) by 14.58 percent. This is a 95.24 percent decrease over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $23.43 million which missed the analyst consensus estimate of $23.48 million by 0.19 percent. This is a 26.40 percent increase over sales of $18.54 million the same period last year.